Toolkit for emerging technologies in laboratory medicine
- PMID: 37314970
- DOI: 10.1515/cclm-2023-0571
Toolkit for emerging technologies in laboratory medicine
Abstract
An emerging technology (ET) for laboratory medicine can be defined as an analytical method (including biomarkers) or device (software, applications, and algorithms) that by its stage of development, translation into broad routine clinical practice, or geographical adoption and implementation has the potential to add value to clinical diagnostics. Considering the laboratory medicine-specific definition, this document examines eight key tools, encompassing clinical, analytical, operational, and financial aspects, used throughout the life cycle of ET implementation. The tools provide a systematic approach starting with identifying the unmet need or identifying opportunities for improvement (Tool 1), forecasting (Tool 2), technology readiness assessment (Tool 3), health technology assessment (Tool 4), organizational impact map (Tool 5), change management (Tool 6), total pathway to method evaluation checklist (Tool 7), and green procurement (Tool 8). Whilst there are differences in clinical priorities between different settings, the use of this set of tools will help support the overall quality and sustainability of the emerging technology implementation.
Keywords: change management; emerging technology (ies); health technology assessment; laboratory medicine; technology readiness level; unmet clinical need.
© 2023 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Coronavirus (COVID-19) update: FDA authorizes first COVID-19 test for self-testing at home [press release] . U.S. Food and Drug Administration; 17th Nov 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... .
-
- Coronavirus (COVID-19) update: FDA authorizes antigen test as first over-the-counter fully at-home diagnostic test for COVID-19 [press release] . FDA; December 15, 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... .
-
- FDA . In vitro diagnostics EUAs – antigen diagnostic tests for SARS-CoV-2 U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .
-
- FDA . In vitro diagnostics EUAs – molecular diagnostic tests for SARS-CoV-2: U.S. food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .
-
- FDA . In vitro diagnostics EUAs – serology and other adaptive immune response tests for SARS-CoV-2: U.S. Food and drug administration; 2023. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-em... .
MeSH terms
LinkOut - more resources
Full Text Sources